| Product NDC: | 0037-1221 |
| Proprietary Name: | Cesamet |
| Non Proprietary Name: | Nabilone |
| Active Ingredient(s): | 1 mg/1 & nbsp; Nabilone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0037-1221 |
| Labeler Name: | Meda Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018677 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20100301 |
| Package NDC: | 0037-1221-50 |
| Package Description: | 1 BOTTLE in 1 CARTON (0037-1221-50) > 50 CAPSULE in 1 BOTTLE |
| NDC Code | 0037-1221-50 |
| Proprietary Name | Cesamet |
| Package Description | 1 BOTTLE in 1 CARTON (0037-1221-50) > 50 CAPSULE in 1 BOTTLE |
| Product NDC | 0037-1221 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Nabilone |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20100301 |
| Marketing Category Name | NDA |
| Labeler Name | Meda Pharmaceuticals Inc. |
| Substance Name | NABILONE |
| Strength Number | 1 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |